Safety first: Tracking adverse events associated with new therapies for people with hemophilia

Michael Recht

doi:10.1111/jth.15188

Safety first: Tracking adverse events associated with new therapies for people with hemophilia

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	3-5
Number of pages	3
Journal	Journal of Thrombosis and Haemostasis
Volume	19
Issue number	S1
DOIs	https://doi.org/10.1111/jth.15188
State	Published - Jan 2021

Keywords

clinical research
emicizumab
hemophilia
mortality
registry

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/jth.15188

Cite this

@article{87394c1b108542c895468d4459bc3a22,

title = "Safety first: Tracking adverse events associated with new therapies for people with hemophilia",

keywords = "clinical research, emicizumab, hemophilia, mortality, registry",

author = "Michael Recht",

year = "2021",

month = jan,

doi = "10.1111/jth.15188",

language = "English (US)",

volume = "19",

pages = "3--5",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell",

number = "S1",

}

TY - JOUR

T1 - Safety first

T2 - Tracking adverse events associated with new therapies for people with hemophilia

AU - Recht, Michael

PY - 2021/1

Y1 - 2021/1

KW - clinical research

KW - emicizumab

KW - hemophilia

KW - mortality

KW - registry

UR - http://www.scopus.com/inward/record.url?scp=85097628096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097628096&partnerID=8YFLogxK

U2 - 10.1111/jth.15188

DO - 10.1111/jth.15188

M3 - Comment/debate

C2 - 33331044

AN - SCOPUS:85097628096

VL - 19

SP - 3

EP - 5

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - S1

ER -

Safety first: Tracking adverse events associated with new therapies for people with hemophilia

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this